QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Congress mandates free vaccines for all—but only until 2029

S. 2857 — Protecting Free Vaccines Act of 2025 · Filed by Ron Wyden (D-OR) · 2 cosponsors · Introduced Sep 18, 2025 · Referred to committee

65%
Transparency
Typical bill: 82%
25/100
Hidden-provision risk
Typical bill: 15/100
Vaccine Access & Cost Removal

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill requires health insurance plans—including Medicare, Medicaid, CHIP, and private group/individual plans—to cover without cost-sharing all vaccines that the CDC's Advisory Committee on Immunization Practices (ACIP) recommended as of October 25, 2024, through December 31, 2029. The coverage applies to the vaccines themselves and their administration, including updated or modified versions of those vaccines approved after the cutoff date. The bill essentially locks in vaccine coverage at 2024 ACIP recommendations, preventing insurers from imposing copays, deductibles, or other out-of-pocket costs for those immunizations.

Why we flagged it

The bill's core mechanism is a mandate requiring insurers to cover ACIP-recommended vaccines without cost-sharing across all major insurance programs. It is a public-health access measure, not a subsidy or carve-out.

What the text implies

  • The October 25, 2024 cutoff date locks in ACIP recommendations as of that specific date, potentially creating a static benefit that does not automatically update if ACIP adds new vaccine recommendations after 2024 (though updated/modified versions of 2024-recommended vaccines are covered).
  • The December 31, 2029 sunset means coverage mandates expire in five years; renewal or extension would require new legislation, creating a cliff risk for vaccine access.

The full analysis lists 5 implications of this text.

Who stands to gain

vaccine manufacturers (Pfizer, Moderna, Merck, Johnson & Johnson, others); healthcare providers and pharmacies (increased vaccine administration volume); insurers (potential offset: reduced cost-sharing revenue but lower disease burden costs)

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record